has anyone died from semaglutide The FDA issued a warning to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 medications, popularly known as Ozempic and Retatrutide for weight loss: Study
Description
Obesity is a major risk factor for obstructive sleep apnea
GLP-1 is your body's natural appetite manager
Procedural sedation in Emergency Medicine 2024 Sedation is a routine aspect of emergency care
These typically resolve as your body adjusts to the medication, but they can be disruptive during the first one to two weeks at each new dose level
Association between glucagon-like peptide-1 receptor agonist use and peri-operative pulmonary aspiration: a systematic review and meta-analysis
